WEKO3
アイテム
医薬品の普及過程--医薬品の採用者間の情報共有におけるMRの役割
https://kindai.repo.nii.ac.jp/records/1344
https://kindai.repo.nii.ac.jp/records/13448f4e3050-e70a-48f2-b2ab-9cc94f2bda1e
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
AA11125284-20090525-0087.pdf (2.4 MB)
|
|
| Item type | ☆学術雑誌論文 / Journal Article(1) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2012-10-01 | |||||||||
| タイトル | ||||||||||
| タイトル | 医薬品の普及過程--医薬品の採用者間の情報共有におけるMRの役割 | |||||||||
| 著者 |
筒井, 万理子
× 筒井, 万理子
|
|||||||||
| 言語 | ||||||||||
| 言語 | jpn | |||||||||
| キーワード | ||||||||||
| 主題 | 医薬品イノベーションの普及, 補完資産, MRマネジメント, 実践共同体, ナレッジ・マネジメント | |||||||||
| 資源タイプ | ||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||
| 資源タイプ | journal article | |||||||||
| 著者(英) | ||||||||||
| en | ||||||||||
| Tsutsui, Mariko | ||||||||||
| 著者 所属 | ||||||||||
| 近畿大学経営学部 | ||||||||||
| 著者所属(翻訳) | ||||||||||
| Kinki University | ||||||||||
| 版 | ||||||||||
| 出版タイプ | VoR | |||||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||
| 出版者 名前 | ||||||||||
| 出版者 | 日本経営学会 | |||||||||
| 書誌情報 |
日本経営学会誌 en : Journal of business management 号 23, p. 87-97, 発行日 2009-05-01 |
|||||||||
| ISSN | ||||||||||
| 収録物識別子タイプ | ISSN | |||||||||
| 収録物識別子 | 18820271 | |||||||||
| 抄録 | ||||||||||
| 内容記述タイプ | Abstract | |||||||||
| 内容記述 | [Abstract] In this paper, we argue that the medical representatives (MRs) play an extreme important role in the medical information diffusion to clinicians. Generally, at the diffusion process of innovations, innovation adopter conducts information gathering (Rogers 2003). As well, in the case of medical diffusion process, the doctors considered as medicine adopters also obtain amount of information from various sources in making decisions to adopt new medicine, which are acquired from academic conferences and seminars, medical journals, word-of-mouth within clinicians, and the information MRs provide. Coleman et al. (1966) showed that the doctors obtained information of new medicine from other doctors who had already used those, which they reduced the uncertainness of new medicine. On the other hand, Van den Bulte and Lilien (2001) reinvestigated the research of Coleman et al. by adding new data, and made conclusion that the marketing effort by medicine companies had more significant impact on medicine diffusion than the internal communication between clinicians. Although the results between Coleman et al. and Van den Butte and Lilien looked like quite different, those two researches will become a complementary relationship if the new viewpoint on MRs' role in the medical diffusionn will be recognized. We conducted a case study of medicine company A, and found that MRs provided doctors with not only drug information but also other clinicians' impressions about new medicine. Clinicians are so busy for daily medical examination and treatment that they cannot have enough time to inquire into and share drug information among other profession. This is why MRs play a significant role as mediators in sharing drug information between doctors. | |||||||||
| 内容記述 | ||||||||||
| 内容記述タイプ | Other | |||||||||
| 内容記述 | Copyright (c) 2009 日本経営学会 , rights: 本文データは学協会の許諾に基づきCiNiiから複製したものである, relation: isVersionOf: http://ci.nii.ac.jp/naid/110007226030 | |||||||||
| 資源タイプ | ||||||||||
| 内容記述タイプ | Other | |||||||||
| 内容記述 | Journal Article | |||||||||
| フォーマット | ||||||||||
| 内容記述タイプ | Other | |||||||||
| 内容記述 | application/pdf | |||||||||
